- Home
- Our company
- Social impact
- Global health equity
- Global health equity news & press releases
Global health equity news & press releases
How borderless mentorship helped South Lake Medical Centre bloom
The partnership with SLMC shines light on another aspect of J&J Impact Ventures, an investment fund within the J&J Foundation, offerings: J&J employees as mentors, who engage directly with staff on strategy and other aspects of the work to accelerate progress.
Mobilizing the community to eliminate preventable blindness in children
Recognizing myopia as a public health problem, the Chinese government launched a comprehensive national plan for the prevention and control of myopia. Village doctors like Pan Taoling have a large role to play in achieving the government’s goals.
Health: the next frontier for impact investing
Health-related impact investments remain limited, even as the field now totals a $715 billion global market. J&J Impact Ventures, an investment fund within the J&J Foundation, is investing in purpose-driven entrepreneurs and their startups in the belief that as their businesses grow, so will their impact.
Janssen Announces Novel Mechanism of Action that Shows Promise Against Dengue in Data Published in Nature
Early-stage research suggests potential to prevent and treat all dengue serotypes With no treatments available, dengue infects up to 400 million people each year and the pace of outbreaks is increasing.[1] This research builds on Johnson & Johnson’s work to advance science against emerging and entrenched global public health threats
Johnson & Johnson Ebola Vaccine Regimen Demonstrated Robust and Durable Immune Response in Adults and Children in Data Published in The Lancet Infectious Diseases
Data show the vaccine regimen induced neutralizing antibody responses in nearly all participating adults and children 21 days after the second dose Adults receiving booster shots two years after initial vaccination regimen showed strong immune responses The data support the potential prophylactic use of the Johnson & Johnson Ebola vaccine regimen to protect adults and children
This nurse leader in Liberia is making sure mothers and babies get the healthcare they need
As Liberia country director for Last Mile Health, Marion Subah is working with the Liberia Ministry of Health to scale and sustain the country’s first national community health worker program.
Johnson & Johnson Launches Network of Global Health Discovery Centers that Aim to Speed Up Science and Tackle Pandemic Threats
J&J Centers for Global Health Discovery (J&J Centers) are a new cornerstone of the Company’s efforts to solve the world’s most pressing health challenges The first J&J Satellite Center is hosted at the London School of Hygiene & Tropical Medicine (LSHTM) and focused on addressing the threat of antimicrobial resistance and tuberculosis J&J Centers will include collaborations with renowned academic institutions that accelerate potentially lifesaving innovations from the lab to the last mile
Prioritizing health worker mental health and well-being is critical to achieving healthcare goals
Health worker burnout was reaching a crisis point even before COVID-19. Tackling burnout needs to begin with addressing the stigma among health workers to reach out for mental health support.
Johnson & Johnson Joins World Health Organization in Efforts to Prevent Spread of Ebola in West Africa
Up to 200,000 Johnson & Johnson Ebola vaccine regimens will be made available as part of a WHO early access clinical program now underway in Sierra Leone Company’s Ebola vaccine regimen also receives Prequalification from the WHO The Johnson & Johnson vaccine regimen is designed to be used proactively to induce immunity against Ebola in adults and children
Meet Teresa Harrison, who is changing how mental healthcare is being delivered in Grimsby, UK
A new model in community-based mental health support pioneered by Mental Health UK is improving quality of life for patients and helping to ease over-burdened primary care practices.
Conduit interview with Kris Sterkens
“We’re supporting the power of local ideas to create real, sustainable change.”
Kenya launches new community health strategy
Co-created by the Johnson & Johnson Center for Health Worker Innovation with the Ministry of Health and other stakeholders, the effort aims to integrate community health workers formally into the health system.
Meet three innovative nurse practitioners who are using a dental clinic to make primary care accessible
Whitney Nash, Michelle Baxter and Beverly Williams Coleman—alums of the Duke-Johnson & Johnson Nurse Leadership Program—discuss how they set up a primary care clinic in the University of Louisville School of Dentistry.
Stop TB Partnership and Johnson & Johnson, with support from USAID and The Global Fund, Announce Price Reduction for SIRTURO® (bedaquiline) for Treatment of Drug-Resistant Tuberculosis in Low- and Middle-Income Countries
Joint efforts aim to accelerate scale-up of WHO-recommended all-oral treatment regimens – a transition urgently needed to help protect the health of people with drug resistant-tuberculosis who are particularly vulnerable during COVID-19 pandemic In 2020, the initiative aims to reach at least 125,000 patients and could save National TB Programs in low- and middle-income countries up to USD$16 million
Johnson & Johnson Announces European Commission Approval for Janssen’s Preventive Ebola Vaccine
This marks the first major regulatory approval of a vaccine developed by Janssen The Ebola vaccine regimen leverages Janssen’s AdVac® technology, plus Bavarian Nordic’s established MVA-BN® technology Janssen’s AdVac® technology is also being used to develop a vaccine candidate to prevent COVID-19
